RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
RT @MaverickNY: This is interesting to see given how many IO trials excluded patients with autoimmune diseases for safety reasons... https:…
RT @MaverickNY: This is interesting to see given how many IO trials excluded patients with autoimmune diseases for safety reasons... https:…
RT @MaverickNY: This is interesting to see given how many IO trials excluded patients with autoimmune diseases for safety reasons... https:…
RT @MaverickNY: This is interesting to see given how many IO trials excluded patients with autoimmune diseases for safety reasons... https:…
RT @MaverickNY: This is interesting to see given how many IO trials excluded patients with autoimmune diseases for safety reasons... https:…
RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
Amazing.
RT @MaverickNY: This is interesting to see given how many IO trials excluded patients with autoimmune diseases for safety reasons... https:…
RT @MaverickNY: This is interesting to see given how many IO trials excluded patients with autoimmune diseases for safety reasons... https:…
This is interesting to see given how many IO trials excluded patients with autoimmune diseases for safety reasons...
#JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies https://t.co/lhkAJtW9IP https://t.co/CqjEp0XRHA
RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
#JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies https://t.co/lhkAJtW9IP https://t.co/EvOUqcw7Hk
RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
Thinking about the use of checkpoint inhibitors in patients with pre-existing autoimmune conditions: using more targeted immunosuppression, e.g. vedolizumab anti-a4b7, could be helpful
RT @PDRennert: that's a bit of good luck, wow, I can think of scenarios where this combo goes sideways https://t.co/EHI4BR9SZt
RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies | Journal for ImmunoTherapy of Cancer | Full Text https://t.co/D1tQ9zbwfi
RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
RT @sitcancer: #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-…
RT @PDRennert: that's a bit of good luck, wow, I can think of scenarios where this combo goes sideways https://t.co/EHI4BR9SZt
that's a bit of good luck, wow, I can think of scenarios where this combo goes sideways
#JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies https://t.co/lhkAJtW9IP https://t.co/aYyLg7xOdr
RT @sitcancer: New #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving a…
Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies @sitcancer https://t.co/yJMfL8UCAW
RT @sitcancer: New #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving a…
New #JITC Case Report: Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies https://t.co/lhkAJtW9IP https://t.co/lkaJ5Qs750